Search icon

NEW YORK MEDICAL COLLEGE

Company Details

Name: NEW YORK MEDICAL COLLEGE
Jurisdiction: New York
Legal type: DOMESTIC NOT-FOR-PROFIT CORPORATION
Status: Active
Date of registration: 16 Jun 1939 (86 years ago)
Entity Number: 40621
ZIP code: 10595
County: Westchester
Place of Formation: New York
Address: ADMINISTRATION BUILDING, SUNSHINE COTTAGE, VALHALLA, NY, United States, 10595

Agent

Name Role
Registered Agent Revoked Agent

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent ADMINISTRATION BUILDING, SUNSHINE COTTAGE, VALHALLA, NY, United States, 10595

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
WK63UJ11C2H7
CAGE Code:
4B851
UEI Expiration Date:
2024-07-02

Business Information

Activation Date:
2023-07-05
Initial Registration Date:
2001-11-14

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
65CJ7
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-06-24
CAGE Expiration:
2029-06-24
SAM Expiration:
2025-06-20

Contact Information

POC:
KARIN AHYOUNG
Phone:
+1 914-594-4454

National Provider Identifier

NPI Number:
1164624748

Authorized Person:

Name:
PROF. MICHAEL SOLOMON GOLIGORSKY
Role:
PROFESSOR, DIRECTOR, RENAL RES INST
Phone:

Taxonomy:

Selected Taxonomy:
1744R1102X - Research Study Specialist
Is Primary:
Yes

Contacts:

Fax:
9145944732

Form 5500 Series

Employer Identification Number (EIN):
131099420
Plan Year:
2015
Number Of Participants:
667
Sponsors Telephone Number:
Plan Year:
2015
Number Of Participants:
883
Sponsors Telephone Number:
Plan Year:
2014
Number Of Participants:
721
Sponsors Telephone Number:
Plan Year:
2014
Number Of Participants:
958
Sponsors Telephone Number:
Plan Year:
2013
Number Of Participants:
732
Sponsors Telephone Number:

History

Start date End date Type Value
2002-02-28 2024-05-29 Address ADMINISTRATION BUILDING, SUNSHINE COTTAGE, VALHALLA, NY, 10595, USA (Type of address: Service of Process)
1983-02-28 2002-02-28 Address ELMWOOD HALL, VALHALLA, NY, 10595, USA (Type of address: Service of Process)
1981-01-29 1983-02-28 Address NEW YORK MEDICAL COLLEGE, ELMWOOD HALL, VALHALLA, NY, 10595, USA (Type of address: Service of Process)
1973-08-21 2024-05-29 Address FIFTH AVE. AT 106TH ST., NEW YORK, NY, 10029, USA (Type of address: Registered Agent)
1970-11-17 1981-01-29 Address 106TH ST. & 5TH AVE., NEW YORK, NY, 10029, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
240529003608 2024-05-17 CERTIFICATE OF CHANGE BY ENTITY 2024-05-17
20150407027 2015-04-07 ASSUMED NAME CORP DISCONTINUANCE 2015-04-07
20150226076 2015-02-26 ASSUMED NAME CORP INITIAL FILING 2015-02-26
020228000775 2002-02-28 CERTIFICATE OF AMENDMENT 2002-02-28
A954415-10 1983-02-28 CERTIFICATE OF AMENDMENT 1983-02-28

USAspending Awards / Contracts

Procurement Instrument Identifier:
N0622A25F0098
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-11-06
Total Dollars Obligated:
102668.00
Current Total Value Of Award:
102668.00
Potential Total Value Of Award:
102668.00
Description:
TUITION AND FEES
Naics Code:
923110: ADMINISTRATION OF EDUCATION PROGRAMS
Product Or Service Code:
U005: EDUCATION/TRAINING- TUITION/REGISTRATION/MEMBERSHIP FEES
Procurement Instrument Identifier:
N0622A24F00KN
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-05-10
Total Dollars Obligated:
102680.00
Current Total Value Of Award:
102680.00
Potential Total Value Of Award:
102680.00
Description:
TUITION AND FEES
Naics Code:
923110: ADMINISTRATION OF EDUCATION PROGRAMS
Product Or Service Code:
U005: EDUCATION/TRAINING- TUITION/REGISTRATION/MEMBERSHIP FEES
Procurement Instrument Identifier:
N0622A24F00K2
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-01-02
Total Dollars Obligated:
98743.00
Current Total Value Of Award:
98743.00
Potential Total Value Of Award:
98743.00
Description:
TUITION AND FEES
Naics Code:
923110: ADMINISTRATION OF EDUCATION PROGRAMS
Product Or Service Code:
U005: EDUCATION/TRAINING- TUITION/REGISTRATION/MEMBERSHIP FEES

USAspending Awards / Financial Assistance

Date:
2023-09-30
Awarding Agency Name:
Department of Education
Transaction Description:
CAMPUS BASED-FWS
Obligated Amount:
12124.12
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2023-09-22
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING - CONSTRUCTION
Obligated Amount:
1900000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2023-09-11
Awarding Agency Name:
Department of Defense
Transaction Description:
GENOMIC AND IMMUNOMIC MECHANISMS OF RESISTANCE DURING DARATUMUMAB POST STEM CELL TRANSPLANTATION IN PATIENTS WITH POOR-RISK T CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA
Obligated Amount:
2660756.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2023-09-08
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
A RANDOMIZED STUDY OF MATERNAL DONOR DERIVED CMV CYTOTOXIC T-LYMPHOCYTES (CTLS) AND VALGANCICLOVIR VS VALGANCICLOVIR IN NEONATES WITH MODERATE/SEVERE MATERNAL ACQUIRED CMV INFECTION - PROJECT SUMMARY CONGENITAL CYTOMEGALOVIRUS (CCMV) INFECTION THAT IS ACQUIRED IN-UTERO, ALTHOUGH AN ORPHAN DISEASE (20-80,000 CASES/YR IN U.S.) IS THE MOST COMMON CONGENITAL INFECTION IN THE U.S. AND THE LEADING CAUSE OF LONG-TERM NEURODEVELOPMENTAL DISABILITIES. CCMV INFECTION REPRESENTS 41% OF ALL CMV ASSOCIATED CHILDHOOD DEATHS. THIS HIGH DEGREE OF MORBIDITY AND MORTALITY IS IN LARGE PART SECONDARY TO THE LARGE CMV GENOME WHOSE GENES ARE DESIGNED TO FACILITATE EVASION, BLOCKING, IMPAIRING AND MODULATION OF HOST ANTI-VIRAL IMMUNE RESPONSES AND AN IMMATURITY AND DEFICIT IN NEONATAL T-CELL ADAPTIVE IMMUNITY AT BIRTH. THIS MALADAPTIVE T-CELL IMMUNE RESPONSE AT BIRTH RESULTS FROM TEMPORAL AND DEVELOPMENTAL IMMUNE DYSREGULATION IN-UTERO WITH A RESULTING BIAS TOWARDS TOLERANCE AND PREVENTING MATERNAL IMMUNOLOGICAL REJECTION, THEREBY SUPPRESSING NORMAL T-CELL MATURATION AND DEVELOPMENT OF MEMORY T-CELLS TO FOREIGN MICROBIAL ANTIGENS. IMPORTANTLY, A POOR CMV SPECIFIC T-CELL ADAPTIVE IMMUNE RESPONSE PREDISPOSES NEONATES WITH CCMV ACQUIRED IN-UTERO TO A SIGNIFICANT INCREASED RISK OF SERIOUS LONG-TERM MORBIDITY AND INCREASED MORTALITY. RESTORING, AT LEAST TEMPORARILY, BOTH CD4 AND CD8 SPECIFIC CMV T- CELL MEDIATED IMMUNITY IN NEONATES WITH MATERNAL ACQUIRED CCMV IS THEREFORE CRITICAL TO ERADICATING PERSISTENT, REFRACTORY AND/OR RESISTANT CMV INFECTION AND UNDESIRABLE LONG-TERM SEQUELAE AND REPRESENTS AN UNMET NEED. WE HAVE PREVIOUSLY ESTABLISHED A VIRAL CYTOTOXIC T-CELL LYMPHOCYTE CONSORTIUM (VIRCTLC) FUNDED UNDER AN FDA ORPHAN GRANT TO MANUFACTURE UNDER GMP CONDITIONS AND ENRICH FOR HAPLOIDENTICAL (MATERNAL) DONOR-DERIVED CMV SPECIFIC CTLS UTILIZING A CMV SPECIFIC PEPTIVATOR® AND THE CYTOKINE CAPTURE SYSTEM (CCS®) ON THE MILTENYI CLINIMACS® DEVICE FOR TREATMENT OF INFANTS AND CHILDREN WITH REFRACTORY/PERSISTENT CMV INFECTION WITH PRIMARY OR SECONDARY T-CELL DEFICIENCIES. WE, THEREFORE, HYPOTHESIZE THAT MANUFACTURING MATERNAL DONOR-DERIVED CMV CTLS AND SUBSEQUENT ADMINISTRATION IN NEONATES WITH MATERNAL ACQUIRED CCMV WILL BE FEASIBLE AND SAFE AND EFFECTIVE IN COMBINATION WITH STANDARD OF CARE (SOC) (VALGANCICLOVIR [VALGCV]) COMPARED TO THOSE TREATED WITH SOC ALONE. THE THREE OVERARCHING AIMS OF THIS FDA ORPHAN GRANT PROPOSAL INCLUDES: 1) TO DETERMINE FEASIBILITY, SAFETY AND COMPARE THE EFFICACY OF MATERNAL DONOR-DERIVED CMV SPECIFIC CTLS WITH SOC VS SOC ALONE; 2) TO CHARACTERIZE THE GENOMIC AND IMMUNOMIC SIGNATURES AND PERSISTENCE OF MATERNAL DONOR-DERIVED CMV CTLS AND COMPARISON OF INNATE AND ADAPTIVE IMMUNE LANDSCAPE POST CMV CTL ADMINISTRATION; AND 3) TO QUANTIFY THE SEVERITY AND INCIDENCE OF LONG-TERM NEUROLOGICAL SEQUELAE AND DEVELOPMENTAL DISABILITIES BETWEEN THE TWO TREATMENT GROUPS. CMV CTLS WILL BE MANUFACTURED UNDER GMP CONDITIONS UTILIZING THE CCS® AND ADMINISTERED EVERY 2 WEEKS UP TO 5 DOSES WITH VALGCV X 6 MONTHS OR VALGCV ALONE. GENOMIC AND IMMUNOMIC STUDIES WILL BE PERFORMED BY SCRNASEQ, MASS CYTOMETRY, HIGH DIMENSIONAL FLOW CYTOMETRY AND NANOSTRING IMMUNOPROFILING. LONG-TERM NEUROLOGICAL SEQUELAE WILL BE MEASURED BY AUDIOGRAMS, BRAIN MRIS, DEVELOPMENTAL TESTING, AMONG OTHERS.
Obligated Amount:
649999.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2023-08-28
Awarding Agency Name:
Department of Commerce
Transaction Description:
AWARD DESCRIPTION: THE WOMEN'S INSTITUTE FOR SCIENCE ENTREPRENEURSHIP (WISE) AIMS TO OFFER UNIQUE OPPORTUNITIES TO WOMEN COLLEGE STUDENTS TO LEVERAGE THEIR EDUCATION IN STEM FIELDS TO EXPLORE NEW SCIENTIFIC CONCEPTS AND LAUNCH NEW BUSINESSES. BY OFFERING A MULTIDISCIPLINARY ENTREPRENEURSHIP EDUCATIONAL OPPORTUNITY, THE PROJECT PROMISES TO OPEN AND EXPAND CAREER TRAJECTORIES FOR PROFESSIONALLY UPWARD MOBILE WOMEN. THEY WOULD HAVE THE POTENTIAL TO POSITION THEMSELVES AS RESPECTED CONTRIBUTORS WHO HAVE OPPORTUNITIES FOR SUBSTANTIVE DIFFERENCES TO THEIR RESPECTIVE FIELDS, THEIR COMMUNITIES, AND WORLD-WIDE.PURPOSE: THE PROJECTS AIMS TO ADDRESS THE FOLLOWING : 1) DESPITE PROGRESS, WOMEN REMAIN UNDERREPRESENTED IN THE BIOMEDICAL SCIENCES; 2. THE UNDERGRADUATE YEARS ARE IDEAL GROUND FOR ENCOURAGEMENT AND RECRUITMENT OF WOMEN INTO THE BIOMEDICAL SCIENCES; AND 3) LONGITUDINAL MENTORING, PARTICIPATION IN ACTUAL RESEARCH, AND SHARING THE JOYS OF DISCOVERY ARE PROVEN METHODS TO GROOM TOMORROW'S SCIENTIFIC LEADERS IN THE HEALTH CARE FIELD.ACTIVITIES TO BE PERFORMED: WISE WILL CONNECT INTERDISCIPLINARY TEAMS OF STUDENTS, RESEARCHERS, FACULTY, AND BIOTECH ENTREPRENEURS TO WORK COLLABORATIVELY TO DEVELOP SYNERGY. WISE WILL WORK CLOSELY WITH THE FACULTY OF LCW, NYMC AND THE TOURO COLLEGE & UNIVERSITY SYSTEM, ALONG WITH THE ENTREPRENEURIAL, BUSINESS, AND SOCIAL VENTURE COMMUNITIES, FOR OFFERED PROGRAMS. THE PROJECT WILL BE IMPLEMENTED IN TWO PHASES: PHASE 1: LCW ENTREPRENEURSHIP EDUCATION AND NETWORKING: STUDENTS TO TAKE ADVANTAGE OF A MENU OF PLANNED ACTIVITIES BEGINNING IN THEIR FRESHMAN YEAR, INCLUDING: SPEAKER'S SERIES, ENTREPRENEURSHIP ROUNDTABLES, RESEARCH PAPERS, INTERNSHIPS, STARTUPNATION (AN ENTREPRENEURIAL-FOCUSED TRIP TO ISRAEL, WITH AN EMPHASIS ON THE STARTUP AND INVESTMENT CLIMATE IN ISRAEL AND SURROUNDING COUNTRIES), MENTORING, E-TREK (IN-PERSON AND VIRTUAL VISITS TO ENTREPRENEURIAL SETTINGS IN THE GREATER NYC AREA TO INTRODUCE STUDENTS TO STARTUP ENVIRONMENTS, ALUMNAE AND RESOURCES), SEED MONEY GRANT PROGRAM AND NEW VENTURE COMPETITION, AND STUDENT CLUBS FOCUSED ON ENTREPRENEURSHIP. PHASE 2: NYMC SCIENTIFIC TRAINING AND BIOTECH INTERNSHIPS: INTERNSHIP FOR 10 PROGRAM PARTICIPANTS, SUMMER RESEARCH (INTENSIVE 8-WEEK RESEARCH PROJECT UNDER THE SUPERVISION OF A FACULTY RESEARCHER), A YEAR-LONG UNDERGRADUATE EXPERIENCE, RESEARCH AND SEMINARS, REAL-WORLD EXPERIENCE, M.S. IN BIOMEDICAL SCIENCE & MANAGEMENT EXPECTED OUTCOMES: THE WOMEN'S INSTITUTE FOR SCIENCE ENTREPRENEURSHIP (WISE) IS A TRANSFORMATIVE PROGRAM THAT, IF SUCCESSFUL, WILL ALLOW FEMALE UNDERGRADUATES TO APPLY THEIR STEM EDUCATION TO CULTIVATE NEW SCIENTIFIC CONCEPTS AND LAUNCH NEW BUSINESSES. WISE AIMS TO CREATE A MULTIDISCIPLINARY ENTREPRENEURSHIP EDUCATIONAL OPPORTUNITY FOR STUDENTS AND LAUNCH CAREERS FOR ALUMNI WHO HAVE THE PROMISE TO MAKE SIGNIFICANT DIFFERENCES TO THEIR COMMUNITIES AND AROUND THE WORLD.INTENDED BENEFICIARIES: STEM TECHNOLOGY, WHICH IS A MAJOR DRIVER OF ECONOMIC DEVELOPMENT IN NEW YORK, BENEFITS DIRECTLY FROM STIMULATION OF NEW COHORTS OF TALENTED WOMEN TO ENTER THE FIELD. THIS PROJECT DRAWS WOMEN INTO NEW YORK MEDICAL COLLEGE AND OTHER ACADEMIC MEDICAL CENTERS IN NEW YORK, ENABLING IT TO OUT-COMPETE OTHER REGIONS OF THE COUNTRY WITH THE UNIQUE PROFESSIONAL OPPORTUNITIES AFFORDED BY THIS PROJECT. IN ADDITION, NEW YORK MEDICAL COLLEGE, WHICH ALREADY IS A MAJOR CONTRIBUTOR TO THE LOCAL ECONOMY, IS UTILIZING THIS PROJECT TO RECRUIT SIGNIFICANT NEW NUMBERS OF PROFESSIONAL WOMEN WHO WILL SERVE AS RESEARCH FELLOWS AND ENTREPRENEURS, FURTHER STIMULATING ECONOMIC DEVELOPMENT IN WESTCHESTER AND THE MID-HUDSON REGION. THROUGH OFFERING A MULTIDISCIPLINARY ENTREPRENEURSHIP EDUCATIONAL OPPORTUNITY, THE PROJECT PROMISES TO OPEN AND EXPAND CAREER TRAJECTORIES FOR NUMEROUS PROFESSIONALLY UPWARD MOBILE WOMEN. SUBRECIPIENT: N/A
Obligated Amount:
825000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
85740878
Mark:
IBIO-NY
Status:
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Mark Type:
SERVICE MARK
Application Filing Date:
2012-09-28
Mark Drawing Type:
Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Mark Literal Elements:
IBIO-NY

Goods And Services

For:
Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare
First Use:
2012-05-01
International Classes:
035 - Primary Class
Class Status:
Active
Serial Number:
74668124
Mark:
CHILDREN'S CANCER RESEARCH FUND OF NEW YORK MEDICAL COLLEGE
Status:
ABANDONED - AFTER INTER-PARTES DECISION
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
1995-05-01
Mark Drawing Type:
Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Mark Literal Elements:
CHILDREN'S CANCER RESEARCH FUND OF NEW YORK MEDICAL COLLEGE

Goods And Services

For:
T-shirts, golf shirts, sweatshirts, caps and jackets
First Use:
1994-04-01
International Classes:
025 - Primary Class
Class Status:
Active
For:
charitable fund raising services to support cancer research
First Use:
1994-04-01
International Classes:
036 - Primary Class
Class Status:
Active

OSHA's Inspections within Industry

Inspection Summary

Date:
2022-08-29
Type:
Complaint
Address:
15 DANA RD., VALHALLA, NY, 10595
Safety Health:
Safety
Scope:
Complete

Inspection Summary

Date:
1999-11-22
Type:
Unprog Rel
Address:
BASIC SCIENCE BLDG NYMC, VALHALLA, NY, 10595
Safety Health:
Health
Scope:
Complete

Inspection Summary

Date:
1998-12-17
Type:
Referral
Address:
VOSBURG PAVILLION, VALHALLA, NY, 10594
Safety Health:
Safety
Scope:
Complete

Inspection Summary

Date:
1998-09-22
Type:
Referral
Address:
SUNSHINE COTTAGE BUILDING, VALHALLA, NY, 10595
Safety Health:
Safety
Scope:
Partial

Inspection Summary

Date:
1998-08-05
Type:
Complaint
Address:
VOSBURG PAVILLION, VALHALLA, NY, 10594
Safety Health:
Health
Scope:
Partial

Tax Exempt

Employer Identification Number (EIN) :
13-1099420
In Care Of Name:
% ADAM HAMMERMAN
Classification:
Educational Organization, Local Association of Employees, Horticultural Organization, Business League, Voluntary Employees' Beneficiary Association (Govt. Emps.), Mutual Ditch or Irrigation Co., Cemetery Company, Other Mutual Corp. or Assoc.
Ruling Date:
1940-08
Deductibility:
Type of organization and use of contribution: A public charity. Deductibility Limitation: 50% (60% for cash contributions)

Court Cases

Court Case Summary

Filing Date:
2009-03-27
Status:
Terminated
Nature Of Judgment:
Missing
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Civil Rights Employment

Parties

Party Name:
BALAZY
Party Role:
Plaintiff
Party Name:
NEW YORK MEDICAL COLLEGE
Party Role:
Defendant

Court Case Summary

Filing Date:
2007-04-02
Status:
Terminated
Nature Of Judgment:
Missing
Jury Demand:
Missing
Nature Of Suit:
Other Labor Litigation

Parties

Party Name:
MUCCI
Party Role:
Plaintiff
Party Name:
NEW YORK MEDICAL COLLEGE
Party Role:
Defendant

Date of last update: 19 Mar 2025

Sources: New York Secretary of State